DMD-001 SUMMIT Registry Study: Long-Term Safety and Quality of Life With AGAMREE in Duchenne Muscular Dystrophy
Age
2 years and older
Sponsor
Catalyst Pharmaceuticals
Countries
United States, Puerto Rico
NCT ID
This information is provided for educational purposes only. Always consult the study investigators before making medical decisions.